Price cap on 2 key cancer drugs increased by 50%
NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…
30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils
Thirty doctors who were found guilty of accepting a foreign trip worth Rs 2 crore to Paris and Monaco, funded by a pharma company, come from at least nine states.…
Eli Lilly pauses Indian obesity awareness campaign after regulatory notices
Eli Lilly has paused an obesity awareness campaign in India in response to a regulatory notice regarding advertising rules for prescription medicines, Reuters reports. In March, India’s Central Drugs Standard…
Obesity drug market to gain as Indians pop the pill and Chinese bring more
Mumbai: A flood of oral GLP1 weight-loss pills, including from China, may redraw India’s obesity treatment market by this year-end, said industry executives and top endocrinologists. Nearly a dozen oral…
Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March
India’s pharmaceutical exports rose more than 2% year on year to $31.11 billion in FY26 despite a 23% decline in March amid the fallout of the West Asia war. A…
Diabetic drug metformin found to act on brain
NEW DELHI: Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…
Unapproved drops for dry eyes pose risks: Govt
NEW DELHI: Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to cancel any permissions granted for these…
Patent rejected for MNC’s cancer drug, generics to follow
NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive…
Quality of generic drugs as good as that of costlier branded cousins: Study
NEW DELHI: A citizen-funded quality study of commonly prescribed medicines has found no difference in quality between expensive branded drugs and the far cheaper generics, including govtsupplied medicines, even as…
Trump announces historic drug price cuts; Move likely to impact Indian pharma sector
The move aims to align American drug costs with the lowest international standards, a strategy that could significantly impact major generic suppliers like India Washington: In a major policy shift…
